2013 Summer Meeting
Click here to go to the previous page
Clinical Considerations: Drug Dosing in Obese and Overweight Patients
Track:
Education Sessions (CE)
Program Code: 125-L01
Date: Monday, June 3, 2013
Time: 2:00 PM to 4:00 PM EST
Location:
101 H, Level 1
PRESENTER(S):
Jeffrey Barletta, Clinical Specialist, Critical Care, Midwestern University, College of Pharmacy
Dr. Erstad is currently a full Professor and Assistant Department Head in the Department of Pharmacy Practice & Science at the University of Arizona College of Pharmacy. He is also a Center Investigator for the Center for Health Outcomes and Pharmacoeconomics Research and a co-director for the Arizona Clinical Research Training Program. His clinical responsibilities are performed at University Medical Center. Dr. Erstads research interests pertain to critical care medicine with an emphasis on patient safety and related outcomes research - he has authored more than 100 peer-reviewed articles and book chapters. Dr. Erstad was on the Board of Directors of the American Society of Health-System Pharmacists and has served on numerous committees and task forces for various organizations including AHRQ, USP, ISPOR, the Society of Critical Care Medicine and the American College of Chest Physicians. Dr. Erstad was the first pharmacist to receive the Society of Critical Care Medicines Shubin-Weil Master Clinician/Teacher Excellence in Bedside Teaching Award.
|
Hanna Phan
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Dr. Erstad is currently a full Professor and Assistant Department Head in the Department of Pharmacy Practice & Science at the University of Arizona College of Pharmacy. He is also a Center Investigator for the Center for Health Outcomes and Pharmacoeconomics Research and a co-director for the Arizona Clinical Research Training Program. His clinical responsibilities are performed at University Medical Center. Dr. Erstads research interests pertain to critical care medicine with an emphasis on patient safety and related outcomes research - he has authored more than 100 peer-reviewed articles and book chapters. Dr. Erstad was on the Board of Directors of the American Society of Health-System Pharmacists and has served on numerous committees and task forces for various organizations including AHRQ, USP, ISPOR, the Society of Critical Care Medicine and the American College of Chest Physicians. Dr. Erstad was the first pharmacist to receive the Society of Critical Care Medicines Shubin-Weil Master Clinician/Teacher Excellence in Bedside Teaching Award.
|
Description
With the increased prevalence of obesity in pediatric and adults, it is imperative that clinicians know how to optimize dosing for this growing issue. Following an overview of general considerations based upon recent literature, participants will apply commonly-used weight calculations to both pediatric and adult medication management in inpatient and ambulatory care settings.
- Apply a process for determining the initial dosing regimen for an adult obese patient when limited dosing information is not available in the usual product information brochures.
- Discuss the limitations of using adjusted body weight calculations for drug dosing in obese patients.
- Utilize a process for determining the initial dosing regimen in a pediatric obese patient when limited dosing information is not available in the usual product information brochures.
No items are available for this session. |